- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Improving the analysis of composite endpoints in rare disease trials ; volume:13 ; number:1 ; day:22 ; month:5 ; year:2018 ; pages:1-9 ; date:12.2018
Orphanet journal of rare diseases ; 13, Heft 1 (22.5.2018), 1-9, 12.2018
- Urheber
-
McMenamin, Martina
- Beteiligte Personen und Organisationen
-
Berglind, Anna
Wason, James M. S.
SpringerLink (Online service)
- DOI
-
10.1186/s13023-018-0819-1
- URN
-
urn:nbn:de:101:1-2018080222421555200418
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McMenamin, Martina
- Berglind, Anna
- Wason, James M. S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Methods for planning and analyzing clinical trials with composite endpoints
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Methods for planning and analyzing clinical trials with composite endpoints
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Methods for planning and analyzing clinical trials with composite endpoints
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting